CD8A and neoplasm: We hypothesize that posttreatment activation of immune system, reduction of immune suppressive factors in the tumor microenvironment, contribute to proliferation and activation of CD8+ T lymphocytes, thus correlating with a favorable cytotoxic effects and treatment response.